Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Synchropet
AddedFeb 16, 2024
UpdatedJun 18, 2026
Synchropet

Synchropet

Biotech firm specializing in MRI-compatible PET scanners for human and small animal research.

HQ
Stony Brook, NY, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize medical imaging, SynchroPET is a biotechnology firm specializing in MRI-compatible PET scanners. The company focuses on developing advanced imaging solutions for both human and small animal research, aiming to enhance research capabilities and clinical assessments. Their compact and versatile PET scanners provide quantitative imaging, opening new avenues for laboratory investigations and potentially shortening drug discovery times.

SynchroPET's technology is utilized by leading researchers, significantly impacting the fields of medical research and patient care. The company has garnered attention for its innovative approach to combining PET and MRI imaging, which offers unprecedented insights. Notable achievements include the successful integration of their scanners in various research institutions, contributing to advancements in drug discovery and diagnostic accuracy.

Synchropet - Similar Companies

Petcoil logo

Petcoil

petcoil.com

PetSimpl logo

PetSimpl

Petsdx Veterinary Imaging logo

Petsdx Veterinary Imaging

petsdx.com

Synchroneuron logo

Synchroneuron

MySimplePetLab logo

MySimplePetLab

mysimplepetlab.com

PepiPets logo

PepiPets

pepipets.com

ABT Molecular Imaging logo

ABT Molecular Imaging

Neuro42 logo

Neuro42

Petri Bio logo

Petri Bio

petribio.com

Syncell logo

Syncell

syncell.com

Alpha-Mri logo

Alpha-Mri

BioSynchronicity logo

BioSynchronicity

Dr.Tail logo

Dr.Tail

drtail.us

Subtle Medical logo

Subtle Medical

subtlemedical.com

HyQ Research Solutions logo

HyQ Research Solutions

hyqrs.com

Synchropet - Quick Facts

Who are Synchropet's competitors?

Companies similar to Synchropet include Petcoil, PetSimpl, Petsdx Veterinary Imaging and Synchroneuron.

When was Synchropet founded?

Synchropet was founded in 2013.

Where is Synchropet's headquarters located?

Synchropet's headquarters is located in Stony Brook, NY, US.

How much has Synchropet raised to-date?

As of Jan 1, 2021, Synchropet has raised a total of $1.5M (USD).

How many employees does Synchropet have?

Synchropet has 30 employees as of Feb 4, 2024.

Synchropet - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • PET Scanners
Tags
  • Healthtech
  • Research
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified